Molecular diagnostic analyzer and reagents

This is a Sources Sought Notice for Tripler Army Medical Center. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 334516 and the successful vendor must be registered in the SAM with this NAICS. Responses to the information requested will assist the Government in determining the appropriate set-aside and acquisition method. The Regional Health Contracting Office - Pacific intends to award an IDIQ type contract for a base period with up to four options to the successful offeror using FAR Part 12 commercial items procedures.

The requirement is for lease of FDA approved instrumentation and software, with purchase of in-vitro diagnostic panels for respiratory (viral and bacterial targets on a single panel) and blood culture (Gram positive, Gram negative, yeast and antimicrobial resistance gene targets).
Targets for the respiratory panel shall include adenovirus, coronavirus, human metapneumovirus, human rhinovirus/enterovirus, influenza A, influenza A H1, influenza A H1-2009, influenza A H3, influenza B, parainfluenza 1, parainfluenza 2, parainfluenza 3, parainfluenza 4, Chlamydia pneumoniea, and Mycoplasma pneumoniae. Targets for the blood culture panel shall include Gram positive organisms (Enterococcus, Lysteria monocytogenes, Staphylococcus, Staphylococcus aureus, Streptococcus, Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes); Gram negative organisms (Acinetobacter baumannii, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenza, Klebsiella oxytoca, Klebsiella pneumoniae, Neisseria meningitides, Pseudomonas aeruginosa, Serratia marcescens); Fungal organisms (Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis); Resistance genes (mecA - methicillin resistance, vancomycin resistance, KPC - carbapenem resistance).
Interested vendors may submit in writing their capabilities and qualifications demonstrating their ability to fulfill the requirement identified in this notice. Responses to this notice should include company name, address, and telephone number, point of contact (POC), and brochures which will allow the Government to understand your offerings and options. Capability statements should be submitted to the attention of Donna Tomita, Contract Specialist, email donna.f.tomita.civ@mail.mil. Telephone responses will not be accepted. Responses must be received no later than 13 Jul 2018 at 10:00 AM Hawaii Standard Time.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required equipment. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.

.